Provision of Primary Medical Services at Charlotte Keel Medical Practice

The procurement contact named on the official notice.

NHS Bristol, North Somerset and South Gloucestershire Integrated Care Board (ICB) seeks to commission Primary Medical Services (General Practice surgery) at Charlotte Keel Medical Centre (L81015) in Bristol for an 8 year contract with an option to extend for up to 2 years (total duration of 10 years).

The current contract is a short term emergency contract due to expire on 31 March 2023.

The successful provider would need to provide the full range of primary medical services from 1 July 2023, mobilising from March 2023.

The practice is situated in the Lawrence Hill ward of Bristol and is ethnically diverse; more than half of the population are BAME (59.6%).

To support the diverse ethnicities the practice has interpreters, counsellors, and welfare benefits advisors accessible on site.

The practice operates from a modern purpose-built health centre and is co-located with a community healthcare team as well as midwives, dentists, and the Citizens Advice Bureau.

The practice has a weighted list size of 19,263 (October 2022) and the annual contract value is £1,837,001, subject to quarterly list size adjustments, Global Sum and Out of Hours adjustments.

Additional income is available from the Quality Outcomes Framework, Direct Enhanced Services, and Local Enhanced Services (LES), noting Local Enhanced Services commissioned by the ICB are offered on an annual basis and are subject to change based on local commissioning priorities.

Based on the current year's LES specifications (2022/23), all the above services contribute to a total financial envelope of c.£2,347,757 per annum.

Including this additionally achievable income, the contract value over 8 years is an estimated £18,782,056, with an estimated additional £4,695,514 for the option to extend for up to 2 years, making an estimated contract value of £23,477,570 over 10 years.

Figures are indicative and represent the likely level of income the provider will receive from the Commissioner.

It does not represent a guaranteed level of income.

An additional envelope of up to £200,000 is available to support non-recurrent costs incurred in the mobilisation and transition to the new contract.

The additional envelope for non-recurrent mobilisation and transition costs is not included in the contract value specified in para.5, however will form part of the final contract value for a total amount of £18,982,056 in the first 8 years.

This procurement is being carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioners.